Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Microbiol Infect ; 21(1): 43-7, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25636926

ABSTRACT

The relationship of non-tuberculous mycobacterial (NTM) infections and survival among solid organ transplant recipients is unknown. We conducted a retrospective cohort study to measure the impact of NTM infection on survival in this patient population, comparing the effect of Mycobacterium abscessus infection with that of infections due to other pathogenic NTM species. We identified 33 patients with NTM infection post-transplantation, 18 with infection that was diagnosed within the first year. Although drug resistance was common among M. abscessus isolates, patients with M. abscessus infection did not have increased mortality compared with patients with other types of NTM infections (p 0.64). In contrast, we observed a significant association overall between early NTM infection and 3-year mortality post-transplantation (hazard ratio 8.76, 95% CI 2.69-28.57). The mortality burden of NTM infection following transplantation may be due to factors other than the virulence of the organisms. Multicentre studies are needed to identify the optimal approach for diagnosing and treating these uncommon but serious infections.


Subject(s)
Mycobacterium Infections, Nontuberculous/mortality , Nontuberculous Mycobacteria/drug effects , Organ Transplantation/adverse effects , Organ Transplantation/mortality , Antitubercular Agents/pharmacology , Drug Resistance, Bacterial , Humans , Mycobacterium Infections, Nontuberculous/complications , Retrospective Studies , Survival Analysis
2.
Transpl Infect Dis ; 16(1): 76-83, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24350627

ABSTRACT

BACKGROUND: The epidemiology of nontuberculous mycobacteria (NTM) disease in solid organ transplant recipients is poorly defined. METHODS: We identified all solid organ transplant recipients with NTM disease at a single center over a 7.5-year period, and collected data on patient demographics, co-morbidities, immunosuppressive medications, and rejection. We conducted a case-control study to identify risk factors for disease, matching 3 control patients to each case patient by date of transplantation. RESULTS: A total of 34 cases of NTM disease occurred during the study period, involving 6 single lung, 13 bilateral lung, 8 heart, 4 liver, 2 kidney, and 1 pancreas-kidney recipients. Cases were predominantly male (24/34), with a median age of 55 years (interquartile range [IQR]: 46-61 years), and developed after a median of 8 months post transplantation (IQR: 2-87 months). Mycobacterium abscessus and Mycobacterium avium complex were the most common pathogens, and the lung (including pleura) was the most common site of disease. In the adjusted case-control analysis, lung transplant recipients had the highest risk of NTM disease. CONCLUSIONS: Additional studies are needed to evaluate the role of targeted surveillance measures for NTM disease in high-risk patients, particularly lung transplant recipients, and to characterize the mechanisms of disease acquisition.


Subject(s)
Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium avium-intracellulare Infection/epidemiology , Organ Transplantation , Tuberculosis, Pulmonary/epidemiology , Age Factors , Case-Control Studies , Cohort Studies , Female , Heart Transplantation , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Liver Transplantation , Logistic Models , Lung Transplantation , Male , Middle Aged , Multivariate Analysis , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium avium Complex/isolation & purification , Mycobacterium avium-intracellulare Infection/immunology , Mycobacterium kansasii/isolation & purification , Mycobacterium marinum/isolation & purification , Pancreas Transplantation , Risk Factors , Sex Factors , Time Factors , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology
3.
Transpl Infect Dis ; 14(2): 149-55, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22260410

ABSTRACT

BACKGROUND: Cytomegalovirus (CMV) disease typically occurs during the first year after solid organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first year is uncommon and not well described. METHODS: We conducted a case-control study to identify potential risk factors and a retrospective cohort study to evaluate 1-month mortality in solid organ transplant (SOT) recipients who developed CMV disease after the first year post transplant, or "very late CMV" (VLCMV), compared with those developing CMV within the first year (CMV Y1), adjusting for demographics, donor and recipient CMV serostatus, immunosuppression, rejection, and co-morbidities. RESULTS: We identified 85 SOT recipients with CMV disease at a single transplant center between January 2006 and October 2008: 23 (27%) had VLCMV and 62 (73%) had CMV Y1. Heart transplantation was independently associated with increased risk (adjusted odd ratio [OR] 4.11; 95% confidence interval [CI] 1.34-12.61; P = 0.01) for VLCMV. Patients with VLCMV had increased 1-month mortality (unadjusted OR 5.39; 95% CI 1.06-27.48; P = 0.02). Mortality was uncommonly attributable to CMV. CONCLUSIONS: CMV disease continues to occur after the first year post solid organ transplantation, particularly in heart transplant recipients, and can be associated with poor outcomes. CMV should be suspected in patients with symptoms or laboratory findings consistent with CMV, even if the patients present >1 year post transplant.


Subject(s)
Cytomegalovirus Infections/virology , Organ Transplantation/adverse effects , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Cytomegalovirus Infections/mortality , Cytomegalovirus Infections/pathology , Female , Humans , Male , Middle Aged , Organ Transplantation/mortality , Risk Factors , Time Factors , Viremia
4.
Nurse Educ Pract ; 7(5): 338-47, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17689461

ABSTRACT

Whilst much has been written on the competence and clinical effectiveness of qualified nurse practitioners, the literature reveals little on the educational experience of student nurse practitioners. This paper reviews an ethnography that examined, over a two-year period, the experiences of student nurse practitioners undertaking a clinical degree programme (B.Sc. (Hons) Nurse Practitioner). The findings revealed the student nurse practitioner experience as a composite of social and cultural transitions, and subsequently Van Gennep's (Van Gennep, A., 1960. The Rites of Passage (Trans). Routledge & Kegan Paul, London) rite of passage model was found to have similarity with this emergent model. Finally, it was noted that, whilst social transition is modelled in the literature in many ways, the stages of a rite of passage had universal application.


Subject(s)
Life Change Events , Nurse Practitioners/education , Social Identification , Socialization , Students, Nursing/psychology , Anthropology, Cultural , Humans , Longitudinal Studies , Models, Psychological , United Kingdom
5.
Transpl Infect Dis ; 8(2): 102-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16734633

ABSTRACT

BACKGROUND: Polyomavirus (primarily BK virus [BKV]) infection is an important cause of chronic renal dysfunction in renal transplant recipients, but its possible contribution to chronic renal dysfunction in non-renal solid organ transplant (NRSOT) recipients has not been fully explored. METHODS: We performed a prospective, cross-sectional study of consecutive NRSOT recipients with unexplained chronic renal dysfunction of at least a 3 months duration. Medical records were reviewed, and polymerase chain reaction was used to amplify BKV-specific sequences from serum and urine samples. The potential associations between various demographic and transplant variables and BKV infection were assessed. RESULTS: Thirty-four consecutive NRSOT recipients (23 lung, 8 liver, 2 heart, 1 heart-lung) with chronic renal dysfunction were enrolled at a median of 3.5 years (range 0.3-12.5 years) post transplantation. Five of the 34 (15%) patients had BKV viruria (range 1040-1.8 x 10(6) copies/mL), but none had BKV viremia. BK viruria was associated with mycophenolate mofetil use (5 of 19 [26%] vs. 0 of 15, P = 0.03) and a history of cytomegalovirus disease (3 of 4 [75%] vs. 2 of 30 [7%], P < 0.01). However, the mean estimated creatinine clearance was similar in patients with or without BKV viruria (49 vs. 47 mL/min). CONCLUSIONS: BKV viruria was present in a proportion of NRSOT patients with otherwise unexplained chronic renal dysfunction. The possibility that BKV infection might contribute to chronic renal dysfunction in this setting warrants further investigation.


Subject(s)
BK Virus/growth & development , Kidney Diseases/virology , Polyomavirus Infections/virology , Transplants , Adult , Aged , Aged, 80 and over , BK Virus/isolation & purification , BK Virus/metabolism , Cross-Sectional Studies , Female , Humans , Immunosuppressive Agents/therapeutic use , Kidney Diseases/blood , Kidney Diseases/etiology , Male , Middle Aged , Polyomavirus Infections/blood , Polyomavirus Infections/etiology , Prospective Studies
7.
Int J Nurs Stud ; 36(1): 57-63, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10375067

ABSTRACT

This paper explores aspects of the controversy and conflict that has arisen within the nursing and medical professions regarding the emergence of nurse practitioners in the United Kingdom (U.K.). Difficulties in establishing satisfactory definitions of nurse practitioners, that allow them to be viewed decisively either within nursing or medical occupational roles, are discussed. The paper argues that the key to the debate may hinge on professional and occupational boundary redefinition which is currently resisted by some members of both the nursing and medical professions. The idea that nurse practitioners may be an evolving and discrete professional group, outside the currently accepted professional and occupational definitions of nursing and medicine, is explored. It is argued that both nursing and medicine are faced with a particular challenge in the nurse practitioner movement that is resulting in conflict as new boundaries are established.


Subject(s)
Nurse Practitioners , Physician's Role , Professional Practice , Humans , United Kingdom
8.
J Adv Nurs ; 27(6): 1278-86, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9663880

ABSTRACT

This study was a qualitative narrative that reviewed the historical developments that led to the integration of nursing and midwifery education with higher education in the United Kingdom (UK). A sample of teachers was investigated with particular reference to role conflicts they may have experienced as a result of integration. In addition to this the views of established academic university staff were assessed. The methodology adopted for the research was an eclectic qualitative one, drawing on several approaches, and sought to inquire into individuals personal perception of these events. In this paper the progression of events, nationally and locally, that led to the educational reforms in nursing and midwifery in the 1990s are examined. This narration includes a brief history of the creation of a new university department. Following this there is detail of how data were collected and analysed from a teacher population within this new department. The findings, whilst difficult to generalize to the wider population of nurse and midwife teachers, demonstrate that the sample of teachers examined, all of whom have been involved in the process of integration, have been exposed to stress that has resulted in role conflict. Established university staff, however, were more objective, expressing some broad anxieties regarding the resource demands and research capability of the new department.


Subject(s)
Education, Nursing/organization & administration , Faculty, Nursing , Nurse Midwives/education , Organizational Innovation , Adult , Female , Humans , Male , Middle Aged , Role , United Kingdom
9.
Clin Infect Dis ; 22(6): 1064-8, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8783711

ABSTRACT

Many studies have examined the etiology of fever complicating neutropenia. Little is known about the etiology of fever occurring immediately following recovery from myelosuppression. We reviewed 165 episodes of fever in patients who were admitted to the University of Pennsylvania Medical Center (Philadelphia) between 1 August 1992 and 15 August 1994 for the treatment of acute leukemia. We included patients who had episodes of fever (temperature of > or = 38 degrees C) for > or = 48 hours within 10 days after an absolute neutrophil count of < or = 500 cells/mm3 was determined. Twenty-nine (20%) of 145 episodes met these criteria. In 5 (17%) of 29 episodes the cause of fever was a bacterial infection, in 6 (21%) of 29 episodes the cause of fever was noninfectious, and in 12 (41%) of 29 episodes the cause of fever was unknown. Six (21%) of 29 episodes were due to documented or suspected fungal infection, four were due to suspected pulmonary aspergillosis, and two were due to systemic candidal infections. Fever following recovery from chemotherapy-induced neutropenia is common. Fungal infections occur frequently after recovery from myelosuppression despite widespread use of empirical and prophylactic antifungal therapy. Improved strategies for diagnosing and preventing fungal infections in patients who have fever following recovery from myelosuppression are clearly needed.


Subject(s)
Fever/etiology , Leukemia/drug therapy , Neutropenia/complications , Adolescent , Adult , Aged , Antineoplastic Agents/adverse effects , Aspergillosis/complications , Bacterial Infections/complications , Candidiasis/complications , Female , Humans , Leukemia/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/drug therapy , Male , Middle Aged , Neutropenia/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...